Five Phase 2 studies ongoing in China in Chronic Obstructive Pulmonary Disorder, asthma, Chronic Rhinosinusitis with Nasap Polyps, Chronic Spontaneous Urticaria and AD. Belenos Biosciences Inc., a ...

A 12 mg dose of BPL-003 (mebufotenin benzoate nasal spray) administered eight weeks after an initial 12 mg, 8 mg or 0.3 mg ...

Roche's experimental multiple sclerosis drug achieved its main goal in one of two key late-stage trials testing it against ...

Q3 2025 Management View CEO Joseph Payne reported that interim Phase II data for ARCT-032, the company’s mRNA therapeutic candidate for cystic fibrosis (CF), showed "treatment with inhaled ...

Study in uncontrolled Graves’ disease (GD) patients treated for 24 weeks showed first-ever potentially disease-modifying outcome with six-month ...

A research and engineering laboratory "Biodynamic Lighting and Phytophotonics" has been opened at Tomsk Polytechnic ...

Dovel & Luner partners Christin Cho and Rick Lyon were sanctioned by U.S. District Judge R. Gary Klausner in the Central ...

Guggenheim Securities 2nd Annual Healthcare Innovation Conference November 10, 2025 9:30 AM ESTCompany ParticipantsAaron ...

The Niners' rookie class was forced into action early because of injuries, but has seen a significant drop in its ...

Researchers have demonstrated that the theoretically optimal scaling for magic state distillation—a critical bottleneck in ...

The middle class in Massachusetts is being hollowed out. Driving the squeeze is a stratospheric rise in inequality.

As the race to develop oncology bispecifics heats up, Pfizer has offered a first look at its strategy to dethrone Keytruda and establish its ...